Nutra Pharma NPHC Stock
Nutra Pharma Price Chart
Nutra Pharma NPHC Financial and Trading Overview
Nutra Pharma stock price | 0.0001 USD |
Previous Close | 1.0E-6 USD |
Open | 0.0001 USD |
Bid | 0 USD x 0 |
Ask | 0 USD x 0 |
Day's Range | 0.0001 - 0.0001 USD |
52 Week Range | 1.0E-5 - 0.0017 USD |
Volume | 1.01M USD |
Avg. Volume | 204.39K USD |
Market Cap | 759.69K USD |
Beta (5Y Monthly) | -3.386971 |
PE Ratio (TTM) | Infinity |
EPS (TTM) | 0 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
NPHC Valuation Measures
Enterprise Value | 8.12M USD |
Trailing P/E | Infinity |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 3.0661266 |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | 32.757 |
Enterprise Value/EBITDA | -5.958 |
Trading Information
Nutra Pharma Stock Price History
Beta (5Y Monthly) | -3.386971 |
52-Week Change | -86.66% |
S&P500 52-Week Change | 20.43% |
52 Week High | 0.0017 USD |
52 Week Low | 1.0E-5 USD |
50-Day Moving Average | 9.46E-5 USD |
200-Day Moving Average | 0.00026095 USD |
NPHC Share Statistics
Avg. Volume (3 month) | 204.39K USD |
Avg. Daily Volume (10-Days) | 543.66K USD |
Shares Outstanding | 7.6B |
Float | 7.52B |
Short Ratio | N/A |
% Held by Insiders | 1.02% |
% Held by Institutions | 0.0069% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 1:40 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2021 |
Most Recent Quarter (mrq) | September 30, 2022 |
Next Fiscal Year End | December 31, 2022 |
Profitability
Profit Margin | 2871.21% |
Operating Margin (ttm) | -557.88% |
Gross Margin | 26.85% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -113.23% |
Return on Equity (ttm) | N/A |
Income Statement
Revenue (ttm) | 247.77K USD |
Revenue Per Share (ttm) | 0 USD |
Quarterly Revenue Growth (yoy) | 466.80% |
Gross Profit (ttm) | 8.47K USD |
EBITDA | -1362257 USD |
Net Income Avi to Common (ttm) | 7.11M USD |
Diluted EPS (ttm) | 0 |
Quarterly Earnings Growth (yoy) | -96.29% |
Balance Sheet
Total Cash (mrq) | N/A |
Total Cash Per Share (mrq) | N/A |
Total Debt (mrq) | 8.1M USD |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | 0.029 |
Book Value Per Share (mrq) | -0.002 |
Cash Flow Statement
Operating Cash Flow (ttm) | -942080 USD |
Levered Free Cash Flow (ttm) | -8158311 USD |
Profile of Nutra Pharma
Country | United States |
State | FL |
City | Plantation |
Address | 1537 NW 65th Avenue |
ZIP | 33313 |
Phone | 954 509 0911 |
Website | https://www.nutrapharma.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | 4 |
Nutra Pharma Corp., a biopharmaceutical company, acquires, licenses, and commercializes pharmaceutical products and technologies, and homeopathic and ethical drugs for the management of pain, neurological disorders, cancer, and autoimmune and infectious diseases primarily in the United States. The company offers Nyloxin and Nyloxin Extra Strength products, which are used as an oral spray for treating lower back pain, migraines, neck aches, shoulder pain, cramps, and neuropathic pain, as well as a topical gel for treating joint pain, and pain associated with arthritis and repetitive stress; Pet Pain-Away, a homeopathic, nonnarcotic, nonaddictive, and overthecounter pain reliever to treat chronic pain in companion animals; Luxury Feet, an over-the-counter pain reliever and antiinflammatory product to treat pain or discomfort due to high heels and stilettos; Nyloxin Military Strength for treating pain to the United States Military and Veteran's Administration; and Equine Pain-Away, an over-the-counter topical pain reliever to relieve pain in horses. It is also involved in developing RPI-78M to treat neurological diseases and autoimmune diseases, including multiple sclerosis, adrenomyeloneuropathy, amyotrophic lateral sclerosis, rheumatoid arthritis, and myasthenia gravis; RPI-MN to treat viral diseases comprising human immunodeficiency virus/AIDS and herpes, as well as for general anti-viral applications; RPI-78 for pain and arthritis; and RPI-70 for pain. The company was incorporated in 2000 and is based in Plantation, Florida.
Q&A For Nutra Pharma Stock
What is a current NPHC stock price?
Nutra Pharma NPHC stock price today per share is 0.0001 USD.
How to purchase Nutra Pharma stock?
You can buy NPHC shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Nutra Pharma?
The stock symbol or ticker of Nutra Pharma is NPHC.
Which industry does the Nutra Pharma company belong to?
The Nutra Pharma industry is Drug Manufacturers-Specialty & Generic.
How many shares does Nutra Pharma have in circulation?
The max supply of Nutra Pharma shares is 7.6B.
What is Nutra Pharma Price to Earnings Ratio (PE Ratio)?
Nutra Pharma PE Ratio is now.
What was Nutra Pharma earnings per share over the trailing 12 months (TTM)?
Nutra Pharma EPS is 0 USD over the trailing 12 months.
Which sector does the Nutra Pharma company belong to?
The Nutra Pharma sector is Healthcare.